[Hormone substitution treatment of the menopause].
González-Merlo
J
J
Departamento de Obstetricia y Ginecología, Hospital Clínico, Facultad de Medicina, Universidad de Barcelona.
Castelo-Branco
C
C
Celades
M
M
D000230:Adenocarcinoma / Q000139:chemically induced / Q000517:prevention & control; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D002979:Climacteric; D004717:Endometrium / Q000187:drug effects / Q000473:pathology; D004958:Estradiol / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006965:Hyperplasia; D008055:Lipids / Q000097:blood; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology / Q000627:therapeutic use; D008593:Menopause / Q000097:blood; D008594:Menopause, Premature; D008875:Middle Aged; D010052:Ovariectomy / Q000009:adverse effects; D011388:Prolactin / Q000097:blood; D011446:Prospective Studies; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000517:prevention & control
D004966:Estrogens, Conjugated (USP); D008055:Lipids; D004958:Estradiol; D011388:Prolactin; D017258:Medroxyprogesterone Acetate
Tratamiento hormonal sustitutivo de la menopausia.